This inventor holds 1 USPTO granted patent. Top assignee: Centre International De Recherches Dermatologiques Galderma. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Gérard Ailhaud: Innovator in Adipocyte Differentiation
Introduction
Gérard Ailhaud is a notable inventor based in Nice, France. He has made significant contributions to the field of medical research, particularly in the differentiation of preadipocytic cells. His work aims to address critical health issues such as insulin resistance and related diseases.
Latest Patents
Gérard Ailhaud holds a patent titled "Stimulating the differentiation of preadipocytic cells and therapies based thereon." This patent focuses on the differentiation of preadipocytic cells into adipocytic cells. It is particularly relevant for correcting insulin-resistance disease states in mammals, including humans. The patent outlines a method of treating preadipocytic cells or patients with an effective amount of specific ligands and fatty acids. This innovative approach has potential applications in treating type II diabetes and cardiovascular disorders such as hypertension and atherosclerosis.
Career Highlights
Gérard Ailhaud is associated with the Centre International De Recherches Dermatologiques Galderma. His work at this institution has allowed him to explore and develop therapies that can significantly impact patient health. His research is characterized by a commitment to advancing medical science and improving treatment options for various conditions.
Collaborations
Gérard has collaborated with esteemed colleagues such as Paul Grimaldi and Irina Safonova. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapies.
Conclusion
Gérard Ailhaud's contributions to the field of adipocyte differentiation represent a significant advancement in medical research. His patent and ongoing work have the potential to improve the lives of many individuals suffering from insulin resistance and related health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
